According to an expert commission in Norway, the Scandinavian country is contemplating whether to use AstraZeneca and Johnson&Johnson as their vaccines. Not long ago, Denmark also made the decision to omit both AstraZeneca and J&J.
But ultimately, it’s the centre-right government that will get to decide on this issue. The expert council – which consists of 13 health professionals and academics, along with Norway’s public health agency have proposed not to use these two vaccines since there have been deaths of people with blood clumps right after getting vaccinated.
”Our goal is to protect as many as possible so quickly as possible so that we can reopen society and get our everyday life back. So it is a difficult decision to recommend not actively using one of the vaccines in the programme. We still think it is the right decision given the virus situation in Norway today.” stated Geir Bukholm – head of infection control at the institute of public health in Norway.
Because of the health authorities’ indications not to use AstraZeneca vaccine, the government came to the expert panel for help to further discuss Norway’s vaccination of adults by the summer.
The expert commission stated that every adult would get the first dose of vaccine by the end of July if Pfizer and Moderna would be used. On the other hand, if AstraZeneca and Johnson&Johnson would be used, the first dose of vaccines on adults would be done by the end of June.